DMPK
From early screening to IND-enabling studies, we deliver reliable data that meets global regulatory standards.
PRECEDO DMPK Platform
— Your Partner from Screening to IND Filing
PRECEDO Drug Metabolism and Pharmacokinetics (DMPK) Platform is led by a team of highly industrial experienced scientists with deep theoretical knowledge and extensive projectmanagment. Our capabilities span a comprehensive assay range for in vitro ADME, in vivo PK/TK, stand alone bioanalytical and exploratory toxicity studies for a broad spectrum of novel therapeutics. All studies are conducted in strict compliance with NMPA, USFDA, and ICH guidelines, ensuring high quality discovery and IND-enabling data from early compound screening to IND-enabling studies.
Why PRECEDO for DMPK Services?
Comprehensive Modality Coverage
- Small molecules
- PROTACs
- Peptides
- Proteins
- Antibodies
- ADCs
- ASOs and siRNAs
High-Quality Data
- 10,000+ compounds/year
- 280+ individual IND-enabling study approvals
Flexible & Expert Team
- 10 years industrial experience on key leaders
- Stable and dedicated team
- Tailored solutions
Reprogramming Cells, Empowering Medicine
©2026 PRECEDO Biotechnology Co., Ltd. Powered by：www.300.cn